Expanding Evidence Leads to New Pharmacogenomics Payer Coverage
dc.contributor.author | Empey, Philip E. | |
dc.contributor.author | Pratt, Victoria M. | |
dc.contributor.author | Hoffman, James M. | |
dc.contributor.author | Caudle, Kelly E. | |
dc.contributor.author | Klein, Teri E. | |
dc.contributor.department | Medical and Molecular Genetics, School of Medicine | en_US |
dc.date.accessioned | 2023-04-05T13:00:55Z | |
dc.date.available | 2023-04-05T13:00:55Z | |
dc.date.issued | 2021-05 | |
dc.eprint.version | Author's manuscript | en_US |
dc.identifier.citation | Empey PE, Pratt VM, Hoffman JM, Caudle KE, Klein TE. Expanding evidence leads to new pharmacogenomics payer coverage. Genet Med. 2021;23(5):830-832. doi:10.1038/s41436-021-01117-w | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/32228 | |
dc.language.iso | en_US | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.isversionof | 10.1038/s41436-021-01117-w | en_US |
dc.relation.journal | Genetics in Medicine | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | PMC | en_US |
dc.subject | Pharmacogenetics | en_US |
dc.subject | Pharmacodynamics | en_US |
dc.subject | Genotype-phenotype discovery | en_US |
dc.subject | Payer coverage | en_US |
dc.title | Expanding Evidence Leads to New Pharmacogenomics Payer Coverage | en_US |
dc.type | Article | en_US |